Roivant Sciences Ltd.

Symbol: ROIV

NASDAQ

11.17

USD

Market price today

  • 2.0678

    P/E Ratio

  • 0.0314

    PEG Ratio

  • 9.00B

    MRK Cap

  • 0.00%

    DIV Yield

Roivant Sciences Ltd. (ROIV) Financial Statements

On the chart you can see the default numbers in dynamics for Roivant Sciences Ltd. (ROIV). Companys revenue shows the average of 42.075 M which is 4.818 % gowth. The average gross profit for the whole period is 36.897 M which is 6.373 %. The average gross profit ratio is 0.852 %. The net income growth for the company last year performance is 0.331 % which equals 0.007 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Roivant Sciences Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.076. In the realm of current assets, ROIV clocks in at 1798.587 in the reporting currency. A significant portion of these assets, precisely 1692.115, is held in cash and short-term investments. This segment shows a change of -0.184% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 304.317, if any, in the reporting currency. This indicates a difference of -6.604% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 428.991 in the reporting currency. This figure signifies a year_over_year change of 0.696%. Shareholder value, as depicted by the total shareholder equity, is valued at 1607.587 in the reporting currency. The year over year change in this aspect is -0.212%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 32.735, with an inventory valuation of 2.76, and goodwill valued at 0, if any. The total intangible assets, if present, are valued at 144.88.

common:word.in-mln

USD
Growth
TTM20232022202120202019

balance-sheet.row.cash-and-short-term-investments

11205.251692.120742055
2185.5
849.6

balance-sheet.row.short-term-investments

15.315.313.60
0
0

balance-sheet.row.net-receivables

190.4632.76.713.8
15.3
11

balance-sheet.row.inventory

17.132.8-16.563.9
0
0

balance-sheet.row.other-current-assets

162.14121.882.254.3
18.5
325

balance-sheet.row.total-current-assets

11718.11798.62146.52187
2219.2
1185.5

balance-sheet.row.property-plant-equipment-net

322.192.386.977
73.9
11.1

balance-sheet.row.goodwill

0000
0
0

balance-sheet.row.intangible-assets

580.95144.900
0
0

balance-sheet.row.goodwill-and-intangible-assets

580.95144.900
0
0

balance-sheet.row.long-term-investments

1090.88304.3325.8289.5
177.2
169.8

balance-sheet.row.tax-assets

0000
0
0

balance-sheet.row.other-non-current-assets

192.4349.525.836.1
6.7
21.4

balance-sheet.row.total-non-current-assets

2186.37591438.6402.7
257.8
202.3

balance-sheet.row.other-assets

0000
0
0

balance-sheet.row.total-assets

13904.472389.62585.12589.7
2477.1
1387.8

balance-sheet.row.account-payables

167.2137.834.620.6
10.3
6.2

balance-sheet.row.short-term-debt

224.2552.411.412.3
7.8
21.2

balance-sheet.row.tax-payables

28.370.50.70.2
1.5
0.4

balance-sheet.row.long-term-debt-total

1754.34429272.5232.7
108.6
122

Deferred Revenue Non Current

0013.70
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-

balance-sheet.row.other-current-liab

448.2415.1128.2180.2
70.4
182.4

balance-sheet.row.total-non-current-liabilities

2024.63509.6339.3308.7
276.2
239.2

balance-sheet.row.other-liabilities

0022.50
0
0

balance-sheet.row.capital-lease-obligations

245.465.273.974.7
64.5
0

balance-sheet.row.total-liab

3052.53782546.2527.7
368.4
450.5

balance-sheet.row.preferred-stock

0000
0
0

balance-sheet.row.common-stock

0000
0
0

balance-sheet.row.retained-earnings

-11478.93-3772.8-2763.7-1918.5
-1109.2
-2309.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

-40.08-2.6-0.91.4
-2.3
2.5

balance-sheet.row.other-total-stockholders-equity

21075.6353834803.63714.8
3143.7
3024.2

balance-sheet.row.total-stockholders-equity

9556.611607.62038.91797.8
2032.2
717

balance-sheet.row.total-liabilities-and-stockholders-equity

13904.472389.62585.12589.7
2477.1
1387.8

balance-sheet.row.minority-interest

1745.15449.8404.5264.2
76.5
220.3

balance-sheet.row.total-equity

11301.762057.42443.42062
2108.7
937.3

balance-sheet.row.total-liabilities-and-total-equity

13904.47---
-
-

Total Investments

1090.88304.3325.8289.5
177.2
169.8

balance-sheet.row.total-debt

1978.59481.4283.9245
180.9
143.2

balance-sheet.row.net-debt

-9211.35-1195.4-1776.5-1810.1
-2004.6
-706.4

Cash Flow Statement

The financial landscape of Roivant Sciences Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.231. The company recently extended its share capital by issuing 379.71, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0.32, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 4.36 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -44269000.000 in the reporting currency. This is a shift of -1.146 from the previous year. In the same period, the company recorded 18.86, -139.43, and -30.14, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -162.71 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 312.3, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019

cash-flows.row.net-income

4352.84-1115.5-924.1-900.2
-519.4
-749.4

cash-flows.row.depreciation-and-amortization

22.7618.95.90
0
0

cash-flows.row.deferred-income-tax

-5334.35-4.4-5.90
0
0

cash-flows.row.stock-based-compensation

178.18217.856585
122.6
58.9

cash-flows.row.change-in-working-capital

24.266.315.771.9
15.3
49.7

cash-flows.row.account-receivables

0000
0
0

cash-flows.row.inventory

0000
0
0

cash-flows.row.account-payables

-7.814.415.43.8
6.6
4.5

cash-flows.row.other-working-capital

32.0820.368.2
8.7
45.1

cash-flows.row.other-non-cash-items

-79.633.4-334.3191.2
-380.3
-383.4

cash-flows.row.net-cash-provided-by-operating-activities

-835.9000
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-2.65-12.7-17.4-5.8
-4.9
-11.4

cash-flows.row.acquisitions-net

5311.78107.900
1771.7
-2.6

cash-flows.row.purchases-of-investments

000-28.3
-68.4
-43.6

cash-flows.row.sales-maturities-of-investments

00320.20
16.4
46.2

cash-flows.row.other-investing-activites

1.13-139.40.62.4
-20
-46.2

cash-flows.row.net-cash-used-for-investing-activites

5310.25-44.3303.3-31.7
1694.8
-57.6

cash-flows.row.debt-repayment

-31.08-30.1-21.60
-32.1
-9.7

cash-flows.row.common-stock-issued

698.53379.7313.4455.8
1354.2
598.9

cash-flows.row.common-stock-repurchased

-220.960.30-0.1
-1188.5
-7.4

cash-flows.row.dividends-paid

-12.32-162.700
0
0

cash-flows.row.other-financing-activites

228.13312.3150.6
83.5
185.2

cash-flows.row.net-cash-used-provided-by-financing-activities

662.32499.5306.8456.3
217.2
767

cash-flows.row.effect-of-forex-changes-on-cash

7.756.300
0
1434

cash-flows.row.net-change-in-cash

5144.42-381.9-67.6-127.6
1335.9
1119.1

cash-flows.row.cash-at-end-of-period

11250.411692.120742141.7
2185.5
849.6

cash-flows.row.cash-at-beginning-of-period

6105.9920742141.72269.3
849.6
-269.6

cash-flows.row.operating-cash-flow

-835.9-843.4-677.7-552.1
-761.8
-1024.2

cash-flows.row.capital-expenditure

-2.65-12.7-17.4-5.8
-4.9
-11.4

cash-flows.row.free-cash-flow

-838.55-856.1-695.2-557.9
-766.7
-1035.6

Income Statement Row

Roivant Sciences Ltd.'s revenue saw a change of 0.108% compared with the previous period. The gross profit of ROIV is reported to be 48.15. The company's operating expenses are 1125.72, showing a change of -10.520% from the last year. The expenses for depreciation and amortization are 18.86, which is a -0.896% change from the last accounting period. Operating expenses are reported to be 1125.72, which shows a -10.520% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 0.111% year-over-year growth. The operating income is -1077.57, which shows a -0.111% change when compared to the previous year. The change in the net income is 0.331%. The net income for the last year was -1230.02.

common:word.in-mln

USD
Growth
TTM20232022202120202019

income-statement-row.row.total-revenue

123.2461.355.323.8
67.7
2.3

income-statement-row.row.cost-of-revenue

15.3213.192.1
1.1
0.6

income-statement-row.row.gross-profit

107.9248.246.321.7
66.6
1.7

income-statement-row.row.gross-profit-ratio

0000
0
0

income-statement-row.row.research-development

512.69---
-
-

income-statement-row.row.selling-general-administrative

322.79---
-
-

income-statement-row.row.selling-and-marketing-expenses

156.19---
-
-

income-statement-row.row.other-expenses

-35.19-62.2-0.1-33.4
0
0

income-statement-row.row.operating-expenses

1156.031125.71258.1496.5
599
750.2

income-statement-row.row.cost-and-expenses

1171.351138.81267498.6
600.1
750.8

income-statement-row.row.interest-income

77.2532.20.41.4
18
5.8

income-statement-row.row.interest-expense

36.182872.8
7.7
7.5

income-statement-row.row.selling-and-marketing-expenses

156.19---
-
-

income-statement-row.row.total-other-income-expensenet

5278.41-147.3288172.4
-28.6
-58.7

income-statement-row.row.ebitda-ratio-caps

0---
-
-

income-statement-row.row.other-operating-expenses

-35.19-62.2-0.1-33.4
0
0

income-statement-row.row.total-operating-expenses

5278.41-147.3288172.4
-28.6
-58.7

income-statement-row.row.interest-expense

36.182872.8
7.7
7.5

income-statement-row.row.depreciation-and-amortization

47.87-30-288.1560.4
532.4
748.5

income-statement-row.row.ebitda-caps

-989.24---
-
-

income-statement-row.row.operating-income

4826.76-1077.6-1211.7-1070.9
-532.4
-748.5

income-statement-row.row.income-before-tax

4265.67-1224.8-923.7-898.5
-561
-807.2

income-statement-row.row.income-tax-expense

27.395.20.41.7
7.1
2.6

income-statement-row.row.net-income

4324.62-1230-924.1-900.2
1200.5
-1042

Frequently Asked Question

What is Roivant Sciences Ltd. (ROIV) total assets?

Roivant Sciences Ltd. (ROIV) total assets is 2389604000.000.

What is enterprise annual revenue?

The annual revenue is 74241000.000.

What is firm profit margin?

Firm profit margin is 0.876.

What is company free cash flow?

The free cash flow is -1.047.

What is enterprise net profit margin?

The net profit margin is 35.091.

What is firm total revenue?

The total revenue is 39.165.

What is Roivant Sciences Ltd. (ROIV) net profit (net income)?

The net profit (net income) is -1230024000.000.

What is firm total debt?

The total debt is 481404000.000.

What is operating expences number?

The operating expences are 1125721000.000.

What is company cash figure?

Enretprise cash is 6670810000.000.